Let’s Reach Your Development Milestones Together

Owen Hitchins, MBA

Chief Commercial Officer

Owen Hitchins is ProtaGene’s Chief Commercial Officer. He brings three decades of global strategic sales, business development, product management, and marketing experience within the life science and drug development industry. Owen plays a key role in developing and executing ProtaGene’s corporate growth strategy, unifying the commercial organization, and expanding customer relationships worldwide.

Mr. Hitchins is an accomplished leader with a strong track record of growing high-performing organizations. Most recently, Owen was the Global Executive Director, Business Development, CMC at LabCorp (formerly Covance), building and expanding new business across Pharma and Biotech accounts in challenging regions across the United States, Europe, and United Kingdom. In addition, Owen has held global business development and leadership positions across CROs (Covance), software companies (Indigo BioAutomation, Accelrys (now Biovia), and Lab Vantage), and instrument/reagent/service providers (Thermo Fisher Scientific and Beckman Coulter).

Mr. Hitchins received a Master’s in Business Administration from Butler University and a Bachelor of Arts in Chemistry from Washington University.

Analytical Solutions from Research to Market

Group Created with Sketch.
Research
Preclinical
Group 2 Created with Sketch.

Discovery – Pre-clinical

Biologic Candidate Evaluation, Optimization and Selection into IND

Group 3 Created with Sketch.
Phase I
Phase II
Phase III
Group 4 Created with Sketch.

Phase I – Phase III

Release, Clinical Data and Characterization Packages for Accelerating Phase I-III Programs through BLA

Group Created with Sketch.
Registration
Market
Group 2 Created with Sketch.

Registration – Market

Commercial-Stage Comparability Testing by Qualified Advanced Methods

Biologic Therapeutics
Platform Expertise

  • bullet Created with Sketch.

    mAbs

  • bullet Created with Sketch.

    Bispecifics/Multispecifics

  • bullet Created with Sketch.

    Recombinant Proteins—Including Complex, Highly Glycosylated Proteins

  • bullet Created with Sketch.

    Multi-subunit Complexes—Protein, Nucleotide, Ligand

  • bullet Created with Sketch.

    Fusion Proteins

  • bullet Created with Sketch.

    Enzyme Replacement Therapies

  • bullet Created with Sketch.

    ADCs and Protein Conjugates

  • bullet Created with Sketch.

    PEGylated Proteins

  • bullet Created with Sketch.

    Biosimilars

  • bullet Created with Sketch.

    Vaccines, Including Subunit/Recombinant

Cell and Gene Therapeutic Platform Expertise

  • bullet Created with Sketch.

    Capsid-based Vectors

  • bullet Created with Sketch.

    Complex, Envelope Vectors

  • bullet Created with Sketch.

    Non-viral Vectors

  • bullet Created with Sketch.

    Genetic Engineering